Näytetään tulokset 1 - 8 / 8
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

Failure of dupilumab in a severe case of hidradenitis suppurativa

DOI
10.1016/j.annder.2023.03.006
Kluger, Nicolas
Annales de dermatologie et de venereologie2023 Julkaisujen tiedon ikoni

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/all.14221
Agache, Ioana; Beltran, Jessica; Akdis, Cezmi; Akdis, Mubeccel; Canelo-Aybar, Carlos; Canonica, Walt...
Allergy2020 Julkaisujen tiedon ikoni

Efficacy and safety of treatment with dupilumab for severe asthma:A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/all.14268
Agache, Ioana; Song, Yang; Rocha, Claudio; Beltran, Jessica; Posso, Margarita; Steiner, Corinna; Alo...
Allergy2020 Julkaisujen tiedon ikoni

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis:analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/09546634.2019.1612836
Cork, Michael J.; Eckert, Laurent; Simpson, Eric L.; Armstrong, April; Barbarot, Sebastien; Puig, Lu...
Journal of dermatological treatment2020 Julkaisujen tiedon ikoni

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma:A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/all.14235
Agache, Ioana; Rocha, Claudio; Beltran, Jessica; Song, Yang; Posso, Margarita; Solà, Ivan; Alonso-Co...
Allergy2020 Julkaisujen tiedon ikoni

Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding:Interdisciplinary expert consensus in Northern Europe

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/jdv.19512
Deleuran, M.; Dezfoulian, B.; Elberling, J.; Knutar, I.; Lapeere, H.; Lossius, A. H.; Schuttelaar, M...
Journal of the european academy of dermatology and venereology2024 Julkaisujen tiedon ikoni

Management of ocular manifestations of atopic dermatitis: A consensus meeting using a modified delphi process

Vertaisarvioitu
Avoin saatavuus
DOI
10.2340/00015555-3629
Thyssen, Jacob P.; Heegaard, Steffen; Ivert, Lena; Remitz, Anita; Agner, Tove; De Bruin-Weller, Marj...
Acta dermato-venereologica2020 Julkaisujen tiedon ikoni

Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI

Vertaisarvioitu
DOI
10.5414/ALX02166
Klimek, L.; Pfaar, O.; Worm, M.; Eiwegger, T.; Hagemann, J.; Ollert, M.; Untersmayr, E.; Hoffmann-So...
Allergologie2020

Failure of dupilumab in a severe case of hidradenitis suppurativa

DOI
10.1016/j.annder.2023.03.006
2023

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/all.14221
2020

Efficacy and safety of treatment with dupilumab for severe asthma:A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/all.14268
2020

Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis:analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/09546634.2019.1612836
2020

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma:A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/all.14235
2020

Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding:Interdisciplinary expert consensus in Northern Europe

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/jdv.19512
2024

Management of ocular manifestations of atopic dermatitis: A consensus meeting using a modified delphi process

Vertaisarvioitu
Avoin saatavuus
DOI
10.2340/00015555-3629
2020

Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI

Vertaisarvioitu
DOI
10.5414/ALX02166
2020